Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 16, 2010

Premium

WaferGen Biosystems this week said that it has appointed Donald Huffman as its new chief financial officer.

Huffman was most recently CFO at Asante Solutions, a medical device company developing a drug-delivery pump. Prior to that, he was CFO at Guava Technologies, EndoSonics, Microcide Pharmaceuticals, Celtrix Pharmaceuticals, and Sanderling Ventures, a biomedical venture capital firm.


Hugh Douglas has joined BioCision as chief operating officer.

Douglas most recently led Bridge4Bio, a global business consulting group. Previously, he was managing director and president of Hoefer, a part of Harvard Bioscience. Douglas was also vice president of the West Coast operations for Amersham Biosciences, now a part of GE Healthcare.

The company has also expanded its corporate advisory board. New members include Lori Kunkel, who has served as chief medical officer at Proteolix/Onyx Pharmaceuticals, vice president of clinical development at Xenocor, and has held other senior positions at Genentech, Chiron, and Genitope; and Paul Nowak, currently CEO of Biotix Holdings and previously CEO and president of VWR International.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.